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Abstract
Background: The response to ovarian stimulation is different among women referring
for assisted reproductive techniques. This difference could be due to different
genotypes in genes related to reproduction such as estrogen receptor beta (ER𝛽 or
ESR2) gene.
Objective: In the present study, we explored the rate of ESR2 gene polymorphism in
infertile women undergoing IVF treatment with different ovarian response to ovulation
induction.
Materials and Methods: A cross-sectional study was performed among 91
infertile women. The relationship between genotype distribution of the +1730 G/A
polymorphism in the ESR2 gene (rs4986938) and the mean number of follicles and
oocytes, their mean ratio, mean number of embryos, mean size of the follicles and
pregnancy rates were measured. The ESR2 gene +1730 G/A polymorphism were
identified by the amplification-refractory mutation system-polymerase chain reaction.
Results:Genotypes GG, GA, and AA of the ESR2 gene presented frequencies of 27.5%,
67%, and 5.5%, respectively, in the infertile women. The results of the study showed that
the mean number of follicles and oocytes, their mean ratio, mean number of embryos,
mean size of the follicles, and pregnancy rates are not related to different genotypes.
Conclusion: According to the endocrine and paracrine factors which are involved in
the ovulation induction and maturation of oocytes, more studies with higher number of
participants are required to confirm the results of the present study; in addition, further
studies are required to find out other gene polymorphisms affecting estrogen receptor
efficacy in the infertile women.
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1. Introduction
Based on academic definition, infertility is a
failure to achieve clinical pregnancy after 12
months of regular unprotected sexual intercourse
(1). It is estimated that infertility affected more
than 70 million couples worldwide especially in
developing countries (2, 3). However, it seems
that with advanced technology to help infertile
couples, the incidence of infertility is decreasing,
for example it was shown that in the United States
of America this incidence declined from 11.2% in
1965 to 9% in 2007. Besides, it was as high as
30% in Sub-Saharan Africa, about 12% in some
European communities, and nearly 8.5% in Canada
(4-6). The prevalence of infertility was highest in
central/eastern Europe, north Africa/Middle East,
sub-Saharan Africa and south/central Asia (7).
There are some data about the infertility rate in
different regions of Iran like Shiraz with infertility
rate of 11.1%, west of Tehran with 12%, Yazd with
5.52% and even in one study, a history of lifetime
primary infertility was present in 24.9% of the
Iranian women (5, 8). Parsanezhad and colleagues
showed that “the average prevalence rate of life
time infertility is 10.9% in Iran and 3.3% of the
population has current infertility. The reported
causes of infertility in the couples include tubal
and pelvic pathology (35%), ovulatory dysfunctions
(15%), male problems (35%), unexplained infertility
(10%), and unusual problems (5%)” (2).
Female factors infertility is due to several factors,
including abnormal hormones and its effect on the
performance of female genital tract (9). Estrogen
plays an important role in fetal development, the
development of secondary sexual characteristics,
fertility cycle, and maintaining pregnancy (10).
In addition, estrogen regulates the growth and
differentiation of endometrial cells (11). Estrogens
are steroid hormones that play a vital role on both
the female and male reproductive systems (12). In
addition, they are important in the cardiovascular
system and in the maintenance of bone tissue
(12, 13). Estrogens imply their actions through a
ligand-activated transcription factor, the estrogen
receptor (ER) (14), which has two isoforms; ERα and
ER𝛽, encoded by different genes (15). ER𝛽 has been
expressed primarily in the ovary, colon, fallopian
tube, lung, adipose, kidney, heart, bladder, adrenal,
testis, prostate, brain and bone, whereas it has
been seen that ER𝛼 are predominantly detected
in testis, liver, ovary, uterus, mammary gland,
adipose, bone, heart, and brain (pituitary gland) (13,
16-18).
The ER𝛽 gene also named as ESR2 gene
is located on chromosome 14q22-24 (19). Two
common single nucleotide polymorphisms was
displayed by screening of the coding region
and part of the 5’ and 3’ regions of the ESR2
gene: G/A exchange at nucleotide 1730 in the 3’
untranslated region in exon 8 (rs4986938) and a
silent 1082 G/A transition in exon 5 (14, 19, 20).
Both polymorphisms have been overrepresented
in ovulatory dysfunctions (19).
Bianco and colleagues found that the +1730 G/A
polymorphism in the ESR2 gene was associated
with an increased risk of developing endometriosis
in infertile women (21).
However, studies on genetic variants of
ESR2 with respect to female infertility are
still controversial. Accordingly, our aim was to
investigate the impact of the ESR2 gene +1730 G/A
polymorphism on ovarian response in IVF cycle.
2. Materials and Methods
This was an analytical research done with cross-
sectional method. In total, 91 eligible samples
referred to the Research and Clinical Center
for Infertility, Yazd, Iran, from February 2014 to
January 2015, were selected consecutively. The
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couples with male infertility and endometriosis
were excluded from the study. The age range of
the studied samples was 21-43 yr with the mean
age of 32.4 ± 4.5 yr. The duration of infertility
was from 1.5 to 21 year with an average of 6.4 ±
2.7 year. The cause of infertility in the selected
population was ovarian disorders with 33.3%,
disorders of the fallopian tube 14%, polycystic ovary
syndrome 26.9%, unknown disorders 9.12%, and
abnormalities in uterine 2.2%, whereas 10.8% were
related to two-factors of infertility.
For ovulation induction, all participants were
treated with antagonist protocol (with prescribed
Gonal, Cetrotide, HMG, and hCG) and other
information such as the number of follicles, ovum,
and embryos as well as chemical pregnancy
outcome after registration by the relevant specialist
was recorded from the patient.
In this study, amplification refractory mutation
system-polymerase chain reaction method
was used to determine the ESR2 gene +1730
G/A polymorphism. In order to design the
required primers, the sequence surrounding
the ESR2 gene was first taken referring
to gene information bank located in the
National Center for Biotechnology Information
online databank (http://www.ncbi.nlm.nih.gov).
Subsequently, suitable primers were designed
by using the Primer3 tool (http://frodo.wi.mit.
edu/cgibin/primer3) and the final analysis
was performed using the Oligo 7 software
package (Table I). Based on the PCR results,
three different alleles AA, GG, and AG were
detected.
DNA extraction was performed according to the
Gene All Kit, Exgene Blood SV mini, 250p, South
Korea. After extraction, the products were run on
1% agarose gel to verify the results and the quality
of the genomic DNA (Figure 1).
Then, the genomic DNA was analyzed for
intended polymorphism using amplification
refractory mutation system-polymerase chain
reaction method. The overall mixed solution of
the used reaction was Taq DNA Pol 2X Master
Mix Red from Ampliqon Company. The solution
containing compounds required for PCR include
a variety of dNTP (0.4 mM), the enzyme Taq
polymerase (0.2 units/μl master mix), and MgCl2
(3 mM); 1X solution of this reaction mixture was
used for a PCR reaction. The total volume of
each tube was 20 μl which contained 10 μl
Master mix, 2 μl Primer, 4 μl genomic DNA, and
4 μl of double distilled water. Amplification was
set by PCR during 35 consecutive cycle and
binding temperature of primers to 65°C for 1
min. Denaturing and elongation processes in all
cycles were done at 94°C and 72°C for 30 sec
and 1 min, respectively. Before the beginning of
the cycle, denaturing of total genomic DNA was
performed for 10 min at 94°C. Moreover, after the
completion of the all cycles, elongation period for
10 min at a temperature of 72°C was considered
for completing the unfinished chains. After the
completion of PCR reactions, the products were
run on 2% agarose gels alongside a 50 bp marker.
After electrophoresis and a dying step with
ethidium bromide, bands were observed using a
UV Gel Doc apparatus (Figure 2).
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Figure 1. The products of DNA extraction were run on 1% agarose gel. DNA samples were not broken as was visualized under
UV light.
Figure 2. Agarose gel electrophoretic analysis of the ESR2 gene +1730 G/A polymorphism: Lane (M) represents the molecular
marker (DNA molecular weight marker). Lanes (1a and1b) represent the AA genotype showing one band at 157 bp. Lanes (2a and
2b, 4a and 4b, 6a and 6b) represent GA genotype that is presented by two bands at 157 bp. Lanes (3a and 3b, 5a and 5b) represent
the GG genotype showing one band at 157 bp.
2.1. Ethical consideration
The study was approved by the ethical
committee of Yazd Reproductive Sciences Institute.
Written consents were taken from all participants
after informing them about the aims and method
of the study.
2.2. Statistical analysis
Data was analyzed using SPSS software
(Statistical Package for the Social Sciences,
version 16.0, SPSS Inc, Chicago, Illinois, USA). Chi-
square test and t test were used for evaluating the
differences between groups. Logistic regression
method was used for confounder adjournment.
3. Results
Our results indicated that most frequent
polymorphism was AG with 67%, while the GG
polymorphism was 27.5% and AA polymorphism
was 5.5%. According to the X2 test and p
= 0.96, there was no statistically significant
relationship between the ESR2 gene +1730 G/A
polymorphism and the result of pregnancy (Table
II).
In each of the ART cycles, the number of
ovum, embryos, and the ratio of ovum to follicle
were calculated, and there was no statistically
significant relationship between these variables
and the ER𝛽 gene +1730 G/A polymorphism status
(Table III).
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The association of polymorphisms with the
number of follicles was examined. For this
purpose, the number of follicles was classified
in three groups: < 5, 5-15, and > 15. Considering
that the majority of the follicle was with GA
polymorphism 60.5% and p = 0.55, there was no
statistically significant relationship between the
number of follicles and the ESR2 gene +1730 G/A
polymorphism (Table IV).
Based on the linear regression analysis, age and
serumestrogen levels were important independent
factors for follicle number in stimulation of ovulation
(Table V).
Based on the logistic regression analysis of
follicle numbers and other factors such as age,
duration of infertility, serum estrogen density,
genotypes, and important infertility factors, the
result of pregnancy is identified (Table VI).




Positive 6 (26.1) 15 (25.4) 1 (20)
Negative 17 (73.9) 44 (74.6) 4 (80)
Total 23 59 5
Data presented as n (%); p-value = 0.96; Chi-square test was used
Table III. The number of ovum, embryos, and the ratio of ovum to follicle based on the ESR2 gene +1730 G/A polymorphism
``````````̀Variable
Polymorphisms
GG GA AA P-value
Number of embryos 6.2 ± 5.3 7.6 ± 6.3 6 ± 4.9 0.5
Number of ovum 16.6 ± 8.3 16.3 ± 9.4 19 ± 8.1 0.8
Ovum to follicle ratio 0.75 ± 0.24 0.73 ± 0.26 0.78 ± 0.25 0.9
Data presented as Mean ± SD; t test was used
Table IV. Relationship between the number of follicles and polymorphism
hhhhhhhhhhhhhhhNumber of follicles
Polymorphisms
GG GA AA P-value
< 5 2 (50) 2 (50) 0 (0)
5-15 9 (20.9) 32 (74.4) 2 (4.7)
> 15 14 (32.6) 26 (60.5) 3 (7)
0.55
Data presented as n (%), Chi-square test was used
Table V. Follicle number determinants based on linear regression analysis using enter model
Effective factors Linear regression Standard deviation T P-value
Age -0.45 0.16 -2.7 0.0001
Duration of infertility 0.055 0.15 0.34 0.73
Serum estrogen density 0.002 0.000 7.8 0.0001
Genotypes -0.5 1.3 3.37 0.7
According to linear regression analysis, the age and serum estrogen density determines the follicle number as an independent
factor
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Table VI. Pregnancy determinants based on logistic regression analysis using enter model
Effective factors Odds ratio Standard deviation P-value
Age 0.96 0.065 0.54
Duration of infertility 1.02 0.06 0.74
Serum estrogen density 1 0.000 0.11
Genotypes 1.3 1.2 0.8
Infertility cause 0.97 0.21 0.89
Follicle number 1.08 0.43 0.04
According to logistic regression analysis, the number of follicles determines the outcome of pregnancy as an independent
factor
4. Discussion
Infertility is caused due to several factors,
including hormones and their effects on the
performance of female genital tract (9). One of the
two women’s sex steroid hormones is estrogen
which is released by the ovaries (12). Estrogen
plays an important role in fetal development, the
development of secondary sexual characteristics,
fertility cycle, and maintaining pregnancy (10).
In addition, estrogen regulates the growth and
differentiation of endometrial cells (11). ER is divided
into alpha (ERα) and beta (ER𝛽) types (15). In
a research, removing beta receptors in mice
leads to low ovum production and eventually
infertility, which is due to the defects in ovarian
tissue (22). In another research on ER𝛽 gene
knockout mice, it was confirmed that ER𝛽 is
essential for normal ovulation but not for sexual
differentiation, reproduction, and lactation (23).
Practical importance of the ESR2 gene +1730 G/A
polymorphism is not clear as it does not lead to
amino acid changes in the ER𝛽 protein. However,
it is possible that the polymorphism is associated
with other regulatory sequence changes that may
affect gene expression and its function (11).
Recently, much attention has been given
to personalized medicine. The patient’s
pharmacogenetics is important in the treatment
of diseases, therefore depending on the patient’s
drug metabolism in the body, medication and
dosage is determined. So, in infertility treatment,
the patient’s genetics effects in response to
treatment should be considered. According to
the mentioned studies, it has been shown that
the ESR2 gene +1730 G/A polymorphism plays
a role in ovulation and therefore we selected
the polymorphism to review its effects on the
outcomes of IVF. To study the role of genetics
response to treatment in infertile patients in this
study, the ESR2 gene +1730 G/A polymorphism
role in the response to treatment of 91 infertile
women were analyzed. Considering the need to
remove the confounding factors in these patients
for studying genetic effects on the response
to treatment, the patients whose infertility were
related to male factors and endometriosis were
excluded. Also, because the purpose of this
study was to evaluate the response of different
polymorphism to the treatment in infertile patients,
the normal cases were not considered.
In Seleem and co-workers’ study, GG genotype
was more frequent than the other genotypes, while
in the current study, the frequency of GA genotype
was more than other genotypes. This difference
could be due to racial differences in the two groups
or the number of the sample (15). To evaluate the
response of patients to treatment in this study,
the number of follicles and number of ovum after
stimulation of ovulation as well as the ratio of ovum
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to follicles were considered. This ratio is important
in the sense that some follicles may be empty
without any ovum. The results of the ratio of ovum
to follicles in all groups was equal, so, there was
no significant difference; however, in the current
study, the number of follicles in the GA group
was more, but this difference was not statistically
significant.
Overall, in the current study, GA group achieved
the highest percentage of pregnancies (25.4%)
while AA group’s was the lowest (20%). Although
there was no similar study in this region to our
knowledge, but we can refer to Sheikhha and
colleagues’ study about ER alpha gene that
showed that 40% of heterozygote Pp group
achieved pregnancy which was the highest
success rate while the lowest rate of pregnancy
was in pp group with 20% (24). So, the highest
responses to treatment in both studies were
in heterozygous genotype group. It could be
due to the factor that for the success of IVF,
the estrogen levels should be at certain level,
while the smaller or greater amounts of it will
have negative consequences in response to the
treatment.
In general, the observed differences in the
number of ova, follicles, and the ratio of embryos
between this study and others’ might be due
to racial and genetic differences between the
groups. In addition, other factors such as treatment
protocol, the profile of patients, their age, and
so on, can be effective. Because the statistical
analysis of our results was not significant, it
should be noted that based on linear regression
analysis, age and serum levels of estrogen are
the independent factors for number of follicle
in stimulating ovulation. Moreover, according
to logistic regression analysis, the number of
follicles determines the outcome of pregnancy,
as an independent factor, regardless of other
factors such as age, duration of infertility, serum
density of estrogen, genotype, and infertility
factor.
5. Conclusion
According to the relatively low percentage
of treatment responses to IVF cycles, more
attention is needed to focus on pharmacogenetics
and patient’s individual response. This study
investigated the importance of a gene involved in
human reproduction. Based on statistical analysis,
the number of follicles is related to the outcome of
pregnancywhile age and estrogen are the effective
factors on follicle numbers. For further study the
role of the ESR2 gene +1730 G/A polymorphism
in infertility, the prevalence of the polymorphism is
necessary to be evaluated in normal populations.
If various differences in infertile women
are identified by further investigations and
determination of polymorphisms in different
genes, proper planning can be done to choose
effective agents in the treatment of each individual
according to the genetic background. This will
eventually lead to an increase in pregnancy rates
in infertile patients, preventing excessive use of
drugs and avoiding to give false hope to infertile
couples.
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